Company Filing History:
Years Active: 2014
Title: Gisela Maria Gonzalez Marinello: Innovator in Vaccine Development
Introduction
Gisela Maria Gonzalez Marinello is a prominent inventor based in Havana, Cuba. He has made significant contributions to the field of immunology, particularly in the development of vaccine compositions for cancer treatment. His innovative approach has the potential to enhance therapeutic options for patients suffering from tumors.
Latest Patents
Gisela holds a patent for a method of making a homogeneous vaccine composition comprising a conjugate of Epidermic Growth Factor (EGF) and a protein known as P64k. This patent, which is crucial for the treatment of tumors, describes a vaccine composition that includes a chemical conjugate of human recombining EGF and P64k. The conjugation reaction is designed to produce this chemical conjugate in a controlled and reproducible manner. Remarkably, the preferred conjugate increases immunogenic activity, leading to significant increases in anti-EGF antibody titers in humans. This innovative vaccine preparation allows for multiple effective dose presentations, enabling an increase in the immunization dose per patient without raising the frequency of immunizations or the number of immunization sites.
Career Highlights
Gisela is affiliated with the Centro de Inmunología Molecular (CIM), where he continues to advance his research and development efforts. His work at CIM has positioned him as a key figure in the field of immunology, particularly in the context of cancer treatment.
Collaborations
Gisela collaborates with talented colleagues such as Gryssell Rodriguez Martinez and Lisel Vina Rodriguez. Their combined expertise contributes to the innovative research environment at CIM.
Conclusion
Gisela Maria Gonzalez Marinello is a dedicated inventor whose work in vaccine development holds promise for improving cancer treatment. His innovative methods and collaborative spirit are paving the way for advancements in immunology.